Skip to content

4/AAccepted Apr 6, 7:31 PM ET

A2A Pharmaceuticals, Inc. 4/A

BMEABiomea Fusion, Inc.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

7:31 PM

Apr 6, 2023

Filed

Apr 6, 2023

Documents

1

Size

4.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.